keyword
https://read.qxmd.com/read/38252597/a-case-of-systemic-lupus-erythematosus-in-a-patient-with-noonan-syndrome-with-recurrent-severe-hypoglycemia
#21
JOURNAL ARTICLE
Shotaro Masuoka, Takashi Tanaka, Miwa Kanaji, Karin Furukawa, Keiko Koshiba, Zento Yamada, Eri Watanabe, Mai Kawazoe, Shun Ito, Ayako Fuchigami, Toshihiro Nanki
Noonan syndrome (NS) is a dominantly inherited genetic disorder with mutations in genes encoding components or regulators of the RAS/mitogen-activated protein kinase pathway. Its diagnosis is based on characteristic features, including typical facial features, a short stature, congenital heart disease, mild developmental delay, and cryptorchidism. Patients with NS sometimes develop autoimmune diseases, such as Hashimoto's thyroiditis and, rarely, systemic lupus erythematosus (SLE). We herein present a 29-year-old Japanese female with NS complicated by SLE and repeated severe hypoglycemia...
January 22, 2024: Modern rheumatology case reports
https://read.qxmd.com/read/38200649/thrombocytopenia-and-disease-outcomes-in-a-cohort-of-patients-with-systemic-lupus-erythematosus-a-post-hoc-analysis-of-the-comosle-egypt-study
#22
JOURNAL ARTICLE
Sally Samy Mohamed, Sherif Mohamed Gamal, Abir Mokbel, Alkhateeb Kadery Alkamary, Ibrahem Siam, Ahmed Soliman, Fatema Talaat Elgengehy
BACKGROUND: Thrombocytopenia ranges from 20% to 40% in patients with systemic lupus erythematosus (SLE). It is usually associated with severe disease manifestations and worse disease outcomes. AIM OF THE STUDY: To identify the frequency of thrombocytopenia in a cohort of Egyptian patients with SLE and to examine the relationship of thrombocytopenia with various disease manifestations and disease outcomes. METHODS: Data on 902 SLE patients were collected, including demographics, clinical, laboratory, immunological findings, and medications...
January 10, 2024: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/38195200/analysis-of-5-year-hospitalization-data-of-patients-with-systemic-lupus-erythematosus-damage-is-a-risk-factor-for-frequent-and-longer-stays
#23
JOURNAL ARTICLE
Çiğdem Çetin, Melodi Gizem Can, Sinem Öztaşkın, Yasemin Yalçınkaya, Ahmet Gül, Murat İnanç, Bahar Artım Esen
OBJECTIVE: The annual hospitalization rate of patients with systemic lupus erythematosus (SLE) is approximately 10%, and hospitalizations are responsible for most of the healthcare expenses. Herein, we analyzed 5-year hospitalization data of SLE patients and determined factors leading to hospitalization. METHODS: Clinical, laboratory, and hospitalization data of SLE patients admitted to our rheumatology clinic in 2015-2020 were retrieved from our SLE database and analyzed...
March 2024: Lupus
https://read.qxmd.com/read/38179378/a-case-of-systemic-lupus-erythematosus-sle-induced-immune-thrombocytopenia-presented-with-a-subdural-hematoma
#24
Diya M Asad, Salem M Tos, Omar R Khalil, Ahmed H Khammash, Abeer A Awesat, Ahmed M Barbarawi, Mohammad A Isa Assadi, Jawad K Alzaatreh, Majd Mohsen, Alaa Qasem
Systemic lupus erythematosus (SLE) is an autoimmune disease that can cause various health problems, including issues with the blood. One common blood-related symptom in SLE is immune thrombocytopenia (ITP), which leads to low platelet counts. In some cases, SLE patients with ITP may develop a rare but serious complication called subdural hematoma (SDH), which is a type of bleeding in the brain. This combination of conditions can be challenging to manage and has a high mortality rate. In a specific case, a 14-year-old girl with chronic ITP developed a sudden headache and was diagnosed with childhood-onset SLE, leading to the development of SDH...
December 2023: Curēus
https://read.qxmd.com/read/38170205/an-overlapping-case-of-igg4-related-disease-and-systemic-lupus-erythematosus-treated-with-belimumab-a-case-based-review
#25
REVIEW
Megumi Iwamoto, Hiromitsu Asashima, Toshiki Sugita, Fumina Kawashima, Naoki Sugita, Akiyoshi Rai, Yuki Kuroda, Akira Kawashima, Daiki Tabuchi, Satoshi Akao, Ryota Sato, Taihei Nishiyama, Hirofumi Toko, Fumika Honda, Ayako Ohyama, Ayako Kitada, Saori Abe, Haruka Miki, Shinya Hagiwara, Yuya Kondo, Hiroto Tsuboi, Isao Matsumoto
IgG4-related disease (IgG4-RD) is a systemic condition in which IgG4+ plasma cell infiltration and fibrosis cause organ swelling and lead to diverse clinical manifestations. Although IgG4-RD typically responds to glucocorticoids (GCs), relapse during tapering occurs and an early GC-sparing approach might therefore be beneficial. Systemic lupus erythematosus (SLE) is a chronic inflammatory disease with multiple symptoms that is also treated with GCs as a first-line therapy. Recently, belimumab, a recombinant human IgG-1λ monoclonal antibody that inhibits B-cell activating factor, was approved, but reports of use for IgG4-RD are scarce...
January 3, 2024: Rheumatology International
https://read.qxmd.com/read/38150055/characteristics-of-patients-with-initial-diagnosis-of-systemic-lupus-erythematosus-in-emergency-department-and-their-outcomes-a-retrospective-single-center-study
#26
JOURNAL ARTICLE
Xiaoying Zhang, Xiaojing Song, Su Lv, Jia Li, Yuebo Jin, Jiayang Jin, Miao Shao, Jihong Zhu, Cheng Chi
STUDY OBJECTIVE: This study aims to investigate the characteristics of patients with an initial diagnosis of systemic lupus erythematosus (SLE) in an emergency department (ED) and their outcomes. METHODS: A total of 147 SLE patients (119 females and 28 males, mean age 26 ± 19 years) who visited the ED of the Peking University People's Hospital between January 2017 and June 2022 were enrolled in the study. Data on demographic information, clinical characteristics, comorbidities, therapy, and outcomes were collected...
December 27, 2023: Clinical Rheumatology
https://read.qxmd.com/read/38073971/an-epidemiology-study-of-adult-immune-thrombocytopenia-patients-in-a-teaching-hospital-in-northeastern-malaysia
#27
JOURNAL ARTICLE
Muhamad Aidil Zahidin, Nurul Izzah Abdul Razak, Noor Haslina Mohd Noor, Muhammad Farid Johan, Zefarina Zulkafli, Abu Dzarr Abdullah, Hisham Atan Edinur
Immune thrombocytopenia (ITP) has been comprehensively studied and understood in Western Europe and various Asia-Pacific regions. However, the epidemiological and clinical-laboratory aspects of ITP in Malaysia remain limited and not well documented. Therefore, this study aims to evaluate the incidence and clinical parameters of ITP using 20-year retrospective data. Medical records for 205 consecutive adult patients with ITP between January 2000 and December 2022 were analyzed. A p-value of <0.05 is considered statistically significant...
November 2023: Curēus
https://read.qxmd.com/read/38059606/gastrointestinal-manifestations-in-systemic-lupus-erythematosus-data-from-an-indian-multi-institutional-inception-inspire-cohort
#28
JOURNAL ARTICLE
Pankti Mehta, Amita Aggarwal, Liza Rajasekhar, Vineeta Shobha, Ashish J Mathew, Chengappa Kavadichanda, Parasar Ghosh, Bidyut Das, Manish Rathi, Akansha Srivastava, Ranjan Gupta, Avinash Jain
OBJECTIVES: To study the prevalence, correlates, and outcomes of GI manifestations in a prospectively enrolled nationwide cohort of SLE in India (INSPIRE). METHODS: It is an observational cohort study with analysis of the baseline database of the INSPIRE cohort with early outcomes assessed till April 10, 2023. Cases with GI manifestations as per the BILAG index were selected, pertinent clinical and laboratory data were retrieved for analysis. Patients with GI manifestations were compared with the rest of the cohort and factors associated with death were determined...
December 6, 2023: Rheumatology
https://read.qxmd.com/read/37930607/tacrolimus-shows-adequate-efficacy-in-patients-with-antiphospholipid-antibodies-associated-thrombocytopenia-a-retrospective-cohort-study
#29
JOURNAL ARTICLE
Yu Shi, Can Huang, Yangzhong Zhou, Hui Jiang, Yongqiang Zhao, Mengtao Li, Xiaofeng Zeng, Jiuliang Zhao
Thrombocytopenia is a common manifestation associated with the presence of antiphospholipid antibodies (aPL). The aim of this study is to investigate the efficacy and safety of tacrolimus treatment in aPL associated thrombocytopenia. This is a single-center retrospective study. Patients who had persistent positive aPL and thrombocytopenia that was treated with tacrolimus were included. A total of 49 patients [38 females (77.6%)] were enrolled from Nov 2013 to Apr 2022 with a median treatment duration of 22 months...
November 6, 2023: Clinical and Experimental Medicine
https://read.qxmd.com/read/37927085/covid-19-and-sle-infection-and-autoimmunity-at-its-best
#30
REVIEW
Naim Mahroum, Abdulrahman Elsalti, Mehmet Fatih Ozkan, Yehuda Shoenfeld
If one had any doubts before the pandemic regarding the correlation between infections and autoimmunity, COVID-19 left us fascinated on the strong bond between the two entities. The immune and autoimmune reactions seen in patients infected with SARS-CoV-2 have served as a base for this assumption. Later on, the use of immunosuppressants such as systemic glucocorticoids, among other biological agents, turned this assumption to a fact. This was no different when it comes to the vaccines against COVID-19. Through several postulated mechanisms these vaccines, although generally considered safe, are thought to have the potential to result in autoimmune reactions making them not more innocent than the infection itself...
December 2023: Lupus
https://read.qxmd.com/read/37908942/factors-influencing-corrected-count-increment-after-platelet-transfusion-in-thrombocytopenic-patients
#31
JOURNAL ARTICLE
Dhananjay Prasad Sahu, Minal Wasnik, Pankaj K Kannauje
Background Platelet transfusion is a life-saving procedure for thrombocytopenic patients. Platelet transfusions can be either prophylactic or therapeutic. Prophylactic platelet transfusion reduces the risk of bleeding before any specific procedure, whereas therapeutic platelet transfusion helps to control active bleeding. Evaluation of the response to platelet transfusion by calculating the corrected count increment (CCI) is important to determine the success of platelet transfusion and to plan subsequent patient management...
September 2023: Curēus
https://read.qxmd.com/read/37906398/serum-calprotectin-as-a-potential-predictor-of-microvascular-manifestations-in-patients-with-antiphospholipid-syndrome
#32
JOURNAL ARTICLE
Yuan Zhao, Wanting Qi, Can Huang, Yangzhong Zhou, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Jiuliang Zhao
INTRODUCTION: Microvascular manifestations constitute a subtype of antiphospholipid syndrome, and those patients have relatively poor prognoses, so it is important to find markers for microvascular manifestations. This study was conducted to explore whether serum calprotectin could be a predictor of microvascular manifestations in antiphospholipid antibody (aPL)-positive patients. METHODS: Consecutive patients with persistent aPL positivity referred to Peking Union Medical College Hospital and age- and sex-matched health controls (HCs) were included...
December 2023: Rheumatology and Therapy
https://read.qxmd.com/read/37885267/thrombocytopenia-in-patients-with-systemic-lupus-erythematosus
#33
JOURNAL ARTICLE
Omer Nuri Pamuk
Thrombocytopenia can be one of the first manifestations of systemic lupus erythematosus and occurs in up to 40% of patients. Additionally, approximately 2% of patients with primary immune thrombocytopenia may develop systemic lupus erythematosus. Systemic lupus erythematosus is a highly heterogeneous disease, and in some patients, it may present mainly with hematological findings. Thrombocytopenia associated with systemic lupus erythematosus is also diverse, ranging from asymptomatic to severe, acute, or chronic cases...
October 2023: European Journal of Rheumatology
https://read.qxmd.com/read/37882232/low-dose-il-2-therapy-in-autoimmune-diseases-an-update-review
#34
REVIEW
Ruizhi Zhang, Yuyang Zhao, Xiangming Chen, Zhuoqing Zhuang, Xiaomin Li, Erxia Shen
Regulatory T (Treg) cells are essential for maintaining self-immune tolerance. Reduced numbers or functions of Treg cells have been involved in the pathogenesis of various autoimmune diseases and allograft rejection. Therefore, the approaches that increase the pool or suppressive function of Treg cells in vivo could be a general strategy to treat different autoimmune diseases and allograft rejection. Interleukin-2 (IL-2) is essential for the development, survival, maintenance, and function of Treg cells, constitutively expressing the high-affinity receptor of IL-2 and sensitive response to IL-2 in vivo ...
October 26, 2023: International Reviews of Immunology
https://read.qxmd.com/read/37874503/ykl-40-in-serum-a-promising-biomarker-of-juvenile-sle-and-strongly-correlated-with-disease-duration
#35
JOURNAL ARTICLE
Asmaa A Ali, Rasha N Yousef, Mai S Elsheikh, Abeer R Salamah, Liang L Wu, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E Behiry
BACKGROUND: The biological function of YKL-40 is not well determined in different inflammatory and autoimmune diseases; however, some data highlighted its possible connection with disease activity. AIM: We investigated the diagnostic utility of serum YKL-40 in patients with SLE and examined its correlation with disease activity. Additionally, we examined any differences in serum YKL-40 levels between juvenile and adult SLE patients. METHODS: We included 78 female patients with SLE and 42 controls...
October 24, 2023: Irish Journal of Medical Science
https://read.qxmd.com/read/37848593/high-risk-groups-of-neonatal-lupus-erythematosus-in-term-infants-a-birth-cohort-study
#36
JOURNAL ARTICLE
Jingran Ma, Zhenghong Li, Hongmei Song, Lejia Zhang
UNLABELLED: This study aims to analyze the clinical characteristics and risk factors of high-risk groups of neonatal lupus erythematosus (NLE) in term infants. High-risk groups of NLE infants whose mothers were positive for anti-SSA, anti-SSB or anti-U1RNP antibodies during pregnancy were enrolled. They were born between February 2013 and February 2020, with a gestational age not less than 37 weeks. We analyzed their clinical data from birth to 24 months after birth. A total of 105 patients in the NLE high-risk group were included...
October 17, 2023: European Journal of Pediatrics
https://read.qxmd.com/read/37840528/the-prognostic-value-of-neutrophile-lymphocyte-ratio-and-serum-chemerin-to-predict-maternal-fetal-complications-in-pregnant-systemic-lupus-erythematosus-patients
#37
JOURNAL ARTICLE
Gabriela Medina, Francisco R González-Cortés, Antonio Sánchez-González, Juan G Vázquez-Rodríguez, Irvin Ordoñez-González, María P Jiménez-Arellano, Grettel García-Collinot, Susana I Morales-Montalvo, Oscar I Florez-Durante, María P Cruz-Domínguez, María F Colorado-Cruz, Miguel A Zurita-Muñoz, Gilberto Cruz-Arteaga, Carolina Sánchez-Enriquez, Luis J Jara, Miguel Á Saavedra
BACKGROUND: Pregnancy in SLE continues to be a challenge. The neutrophil-to-lymphocyte ratio (NLR) and chemerin are predictors of preeclampsia in the general population; however, their role as predictors of maternal-fetal complications in pregnant SLE patients has not been analyzed. OBJECTIVE: To investigate the prognostic value of NLR and serum chemerin, to predict maternal-fetal complications in pregnant SLE patients, and compare both biomarkers among three study groups...
October 2023: Lupus
https://read.qxmd.com/read/37804186/overlapping-systemic-lupus-erythematosus-seropositive-erosive-rheumatoid-arthritis-and-anca-associated-vasculitis-a-case-report-and-literature-review
#38
JOURNAL ARTICLE
Emma Reesor, Sankalp Virendrakumar Bhavsar
The overlap of rheumatoid arthritis and systemic lupus erythematosus is well described, with a syndrome known as 'rhupus'. ANCA-associated vasculitis, however, is uncommonly associated with other autoimmune conditions. Here we present a case of lupus, rheumatoid arthritis, and ANCA-associated vasculitis, with significant time elapsed between presentations, resulting in an accumulation of the three diagnoses over the course of 35 years. The patient was diagnosed with lupus at age 45, presenting with inflammatory polyarthritis, thrombocytopenia, leukopenia, positive ANA, positive anti-DNA, and hypocomplementemia...
October 7, 2023: Modern rheumatology case reports
https://read.qxmd.com/read/37797401/in-cis-benign-socs1-variants-linked-to-enhanced-interferon-signaling-and-autoimmunity
#39
JOURNAL ARTICLE
Yan Du, Kailey E Brodeur, Evan Hsu, Liang Chen, Qian Chen, Meng Liu, Qi Cheng, Seymour Rosen, Thomas F Michniacki, Janet Chou, Mindy S Lo, Craig D Platt, Pui Y Lee
We aimed to characterize the genetic basis of disease in a family with multiple autoimmune manifestations, including systemic lupus erythematosus (SLE), immune thrombocytopenia, and autoimmune thyroiditis. Whole exome sequencing (WES) was conducted to identify candidate variants, which were analyzed by flow cytometry, immunoblotting, immunoprecipitation, and luciferase reporter assay in transfected 293T cells. Gene expression in peripheral blood mononuclear cells (PBMC) was profiled by bulk RNA sequencing and plasma cytokines were measured by proximity extension assay...
October 3, 2023: Journal of Autoimmunity
https://read.qxmd.com/read/37794618/risk-factors-for-pulmonary-arterial-hypertension-in-patients-with-systemic-lupus-erythematosus-a-systematic-review-and-expert-consensus
#40
JOURNAL ARTICLE
Tatsuya Atsumi, Sang-Cheol Bae, Hong Gu, Wen-Nan Huang, Mengtao Li, Mandana Nikpour, Masato Okada, David Prior, Petar Atanasov, Xiaobin Jiang, Liam Wilson, Paul Bloomfield, David Bin-Chia Wu, Yogeshwar Makanji
OBJECTIVE: This study aimed to identify risk factors associated with the development of pulmonary arterial hypertension (PAH) in patients with systemic lupus erythematosus (SLE). METHODS: We conducted a systematic literature review of studies focusing on adult patients classified as having SLE-related PAH by searching the electronic databases Embase, Medline, Medline in-progress, Wanfang, China National Knowledge Infrastructure, Ichushi Web, Kmbase, and KoreaMed...
October 4, 2023: ACR open rheumatology
keyword
keyword
72645
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.